New DNA-based PCR approaches for rapid real-time detection and prevention of group B streptococcal infections in newborns and pregnant women

Reproductive Medicine Review

Volumn 11, Issue 1, 2003, Pages 25-41

  Bergeron, Michel G ^a   Ke, Danbing ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BACTEREMIA; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; CHEMOPROPHYLAXIS; DNA DETERMINATION; FEMALE; HUMAN; HYBRIDIZATION; INCIDENCE; INFECTION PREVENTION; MAJOR CLINICAL STUDY; NEWBORN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESEARCH; REVIEW; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION;

EID: 4143133377     PISSN: 09622799     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0962279904001036     Document Type: Review

References (75)

1. Ruoff KL, Whiley RA, Beighton D. Streptococcus. In Murray PR et al. (eds.) Manual of Clinical Microbiology (7th edn). Washington DC: ASM Press, pp. 283-96.
2. Keefe GP. Streptococcus agalactiae mastitis: a review. Can Vet J 1997; 38: 429-37.
3. Rowen JL, Baker CJ. Group B streptococcal infections. In Feigin RD, Cherry, JD (eds). Textbook of Pediatric Infectious Diseases (4th edn). Philadelphia: W.B. Saunders, 1998, pp. 1089-106.
4. Schuchat A. Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin Microbiol Rev 1998; 11: 497-513.
5. Zangwill KM, Schuchat A, Wenger JD. Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. Mor Mortal Wkly Rep CDC Surveill Summ 1992; 41: 25-32.
6. Schrag SJ et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 2000; 342: 15-20.
7. Mohle-Boetani JC et al. Comparison of prevention strategies for neonatal group B streptococcal infection. A population-based economic analysis. JAMA 1993; 270: 1442-8.
8. Regan JA et al. Colonization with group B streptococci in pregnancy and adverse outcome. VIP Study Group. Am J Obstet Gynecol 1996; 174: 1354-60.
9. Krohn MA, Hillier SL, Baker CJ. Maternal peripartum complications associated with vaginal group B streptococci colonization. J Infect Dis 1999; 179: 1410-15.
10. Boyer KM et al. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. II. Predictive value of prenatal cultures. J Infect Dis 1983; 148: 802-9.
11. Schuchat A et al. Multistate case-control study of maternal risk factors for neonatal group B streptococcal disease. The Active Surveillance Study Group. Pediatr Infect Dis J 1994; 13: 623-9.
12. Schimmel MS, Samueloff A, Eidelman AI. Prevention of neonatal group B streptococcal infections. Is there a rational prevention strategy? Clin Perinatol 1998; 25: 687-97.
13. Stoll BJ, Schuchat A. Maternal carriage of group B streptococci in developing countries. Pediatr Infect Dis J 1998; 17: 499-503.
14. Baker CJ, Edwards MS. Group B streptococcal infections. In Remington J, Klein JO (eds.) Infectious Diseases of the Fetus and Newborn Infant (4th edn). Philadelphia: W.B. Saunders, 1995, pp. 980-1054.
15. Kalliola S et al. Neonatal group B streptococcal disease in Finland: a ten-year nationwide study. Pediatr Infect Dis J 1999; 18: 806-10.
16. Isaacs D, Royle JA. Intrapartum antibiotics and early onset neonatal sepsis caused by group B Streptococcus and by other organisms in Australia. Australasian Study Group for Neonatal Infections. Pediatr Infect Dis J 1999; 18: 524-8.
17. Embleton N, Wariyar U, Hey E. Mortality from early onset group B streptococcal infection in the United Kingdom. Arch Dis Child Fetal Neonatal Ed 1999; 80: F139-41.
18. Moses LM et al. Early onset group B streptococcal neonatal infection in Oxford 1985-96. Arch Dis Child Fetal Neonatal Ed 1998; 79: F148-49.
19. Lachenauer CS et al. Serotypes VI and VIII predominate among group B streptococci isolated from pregnant Japanese women. J Infect Dis 1999; 179: 1030-3.
20. Varki A et al. (eds) Essentials of Glycobiology. New York: Cold Spring Harbor Laboratory Press, 1999.
21. Koneman EW et al. Colour Atlas and Textbook of Diagnostic Microbiology (5th edn). Philadelphia: Lipincott-Raven Publishers, 1997.
22. Wibawan IW, Lammler C. Properties of group B streptococci with protein surface antigens X and R. J Clin Microbiol 1990; 28: 2834-6.
23. Harrison LH et al. Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. Maryland Emerging Infections Program. J Infect Dis 1998; 177: 998-1002.
24. Blumberg HM et al. Invasive group B streptococcal disease: the emergence of serotype V. J Infect Dis 1996; 173: 365-73.
25. Andrews JI et al. Group B streptococci causing neonatal bloodstream infection: antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere. Am J Obstet Gynecol 2000; 183: 859-62.
26. Lin FY et al. Antibiotic susceptibility profiles for group B streptococci isolated from neonates, 1995-1998. Clin Infect Dis 2000; 31: 76-9.
27. Campbell JR et al. Group B streptococcal colonization and serotype-specific immunity in pregnant women at delivery. Obstet Gynecol 2000; 96: 498-503.
28. Quentin R et al. Characterization of Streptococcus agalactiae strains by multilocus enzyme genotype and serotype: identification of multiple virulent clone families that cause invasive neonatal disease. J Clin Microbiol 1995; 33: 2576-81.
29. Levy NJ et al. Potentiation of virulence by group B streptococcal polysaccharides. J Infect Dis 1984; 149: 851-60.
30. Bohnsack JF et al. A role for C5 and C5a-ase in the acute neutrophil response to group B streptococcal infections. J Infect Dis 1997; 175: 847-55.
31. Gibson RL, Nizet V, Rubens CE. Group B streptococcal beta-hemolysin promotes injury of lung microvascular endothelial cells. Pediatr Res 1999; 45: 626-34.
32. Laboratory of Genomics of Microbial Pathogens (2000) Streptococcus agalactiae Genome. http://www. pasteur.fr/recherche/unites/gmp/Gmp_projects. html#sa
33. Jones AL, Knoll KM, Rubens CE. Identification of Streptococcus agalactiae virulence genes in the neonatal rat sepsis model using signature-tagged mutagenesis. Mol Microbiol 2000; 37: 1444-55.
34. Winram SB et al. Characterization of group B streptococcal invasion of human chorion and amnion epithelial cells in vitro. Infect Immun 1998; 66: 4932-41.
35. Noya FJ et al. Unusual occurrence of an epidemic of type Ib/c group B streptococcal sepsis in a neonatal intensive care unit. J Infect Dis 1987; 155: 1135-44.
36. Olver WJ et al. Neonatal group B streptococcal disease associated with infected breast milk. Arch Dis Child Fetal Neonatal Ed 2000; 83: F48-9.
37. Glezen WP, Alpers M. Maternal immunization. Clin Infect Dis 1999; 28: 219-24.
38. Jones DE et al. Rapid identification of pregnant women heavily colonized with group B streptococci. J Clin Microbiol 1983; 18: 558-60.
39. Food and Drug Administration. Risks of devices for direct detection of group B streptococcal antigen. J Nurse Midwifery 1997; 42: 408-9.
40. Schuchat A. Neonatal group B streptococcal disease - screening and prevention. N Engl J Med 2000; 343: 209-10.
41. Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: a public health perspective. Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep 1996; 45: 1-24.
42. Facklam RR et al. Presumptive identification of group A, B, and D streptococci. Appl Microbiol 1974; 27: 107-13.
43. de la Rosa M et al. New Granada Medium for detection and identification of group B streptococci. J Clin Microbiol 1992; 30: 1019-21.
44. Gil EG et al. Evaluation of the Granada agar plate for detection of vaginal and rectal group B streptococci in pregnant women. J Clin Microbiol 1999; 37: 2648-51.
45. Yancey MK et al. Assessment of rapid identification tests for genital carriage of group B streptococci. Obstet Gynecol 1992; 80: 1038-47.
46. Baker CJ. Inadequacy of rapid immunoassays for intrapartum detection of group B streptococcal carriers. Obstet Gynecol 1996; 88: 51-5.
47. Kontnick CM, Edberg SC. Direct detection of group B streptococci from vaginal specimens compared with quantitative culture. J Clin Microbiol 1990; 28: 336-9.
48. Yancey MK et al. Use of a DNA probe for the rapid detection of group B streptococci in obstetric patients. Obstet Gynecol 1993; 81: 635-40.
49. Bourbeau PP, Heiter BJ, Figdore M. Use of Gen-Probe AccuProbe Group B streptococcus test to detect group B streptococci in broth cultures of vaginal-anorectal specimens from pregnant women: comparison with traditional culture method. J Clin Microbiol 1997; 35: 144-7.
50. Rosa C, Clark P, Duff P. Performance of a new DNA probe for the detection of group B streptococcal colonization of the genital tract. Obstet Gynecol 1995; 86: 509-11.
51. Mawn JA, Simpson AJ, Heard SR. Detection of the C protein gene among group B streptococci using PCR. J Clin Pathol 1993; 46: 633-6.
52. Backman A et al. Evaluation of an extended diagnostic PCR assay for detection and verification of the common causes of bacterial meningitis in CSF and other biological samples. Mol Cell Probes 1999; 13: 49-60.
53. Wang Q et al. V2 regions of 16S ribosomal RNA used as a molecular marker for the species identification of streptococci in peripheral blood and synovial fluid from patients with psoriatic arthritis. Arthritis Rheum 1999; 42: 2055-9.
54. Hall LM, Duke B, Urwin G. An approach to the identification of the pathogens of bacterial meningitis by the polymerase chain reaction. Eur J Clin Microbiol Infect Dis 1995; 14: 1090-4.
55. Ke D et al. Development of conventional and real-time PCR assays for the rapid detection of group B streptococci. Clin Chem 2000; 46: 324-31.
56. Bergeron MG et al. Rapid detection of group B streptococci in pregnant women at delivery. N Engl J Med 2000; 343: 175-9.
57. Podbielski A, Blankenstein O, Lutticken R. Molecular characterization of the cfb gene encoding group B streptococcal CAMP-factor. Med Microbiol Immunol (Berl) 1994; 183: 239-56.
58. Wittwer CT et al. The LightCycler: a microvolume multisample fluorimeter with rapid temperature control. Biotechniques 1997; 22: 176-81.
59. Northrup MA et al. A miniature analytical instrument for nucleic acids based on micromachined silicon reaction chambers. Anal Chem 1998; 70: 918-22.
60. Heid CA et al. Real time quantitative PCR. Genome Res 1996; 6: 986-94.
61. Woo TH et al. Identification of pathogenic Leptospira genospecies by continuous monitoring of fluorogenic hybridization probes during rapid-cycle PCR. J Clin Microbiol 1997; 35: 3140-6.
62. Christel LA et al. Rapid, automated nucleic acid probe assays using silicon microstructures for nucleic acid concentration. J Biomech Eng 1999; 121: 22-7.
63. Tyagi S, Kramer FR. Molecular beacons: probes that fluoresce upon hybridization. Nat Biotechnol 1996; 14: 303-8.
64. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn. Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. Pediatrics 1997; 99: 489-96.
65. Committee on Obstetric Practice, American College of Obstetrics and Gynecologists. ACOG committee opinion, No. 173. Prevention of early-onset group B streptococcal disease in newborns. Int J Gynaecol Obstet 1996; 54: 197-205.
66. Jafari HS et al. Barriers to prevention of perinatal group B streptococcal disease. Pediatr Infect Dis J 1995; 14: 662-7.
67. Towers CV et al. Potential consequences of widespread antepartal use of ampicillin. Am J Obstet Gynecol 1998; 179: 879-83.
68. Baker CJ. Vaccine prevention of group B streptococcal disease. Pediatr Ann 1993; 22: 711-14.
69. Baker CJ et al. Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib. J Infect Dis 1999; 179: 142-50.
70. Kasper DL et al. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J Clin Invest 1996; 98: 2308-14.
71. Baker CJ et al. Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy women. J Infect Dis 2000; 182: 1129-38.
72. Gravekamp C et al. Alpha C protein as a carrier for type III capsular polysaccharide and as a protective protein in group B streptococcal vaccines. Infect Immun 1999; 67: 2491-6.
73. Paoletti LC et al. Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid conjugate vaccine. Infect Immun 1994; 62: 3236-43.
74. Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: revised guidelines from CDC. Morb Mortal Wkly Rep 2002; 51: 1-22.
75. Haberland CA et al. Perinatal screening for group B streptococci: cost-benefit analysis of rapid polymerase chain reaction. Pediatrics 2002; 110: 471-80.